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Follow-up study of the treatment 
outcomes at a psychiatric trauma  
clinic for refugees
Cæcilie Buhmann, MD, PhD*, Erik Lykke Mortensen, MSc**, Merete Nordentoft, 
DrMSc***, Jasmina Ryberg, MD*, Morten Ekstrøm, MD, PhD*
Abstract 
Purpose: To describe change in mental 
health after treatment with antidepressants 
and trauma-focused cognitive behavioral 
therapy. 
Methods: Patients receiving treatment at the 
Psychiatric Trauma Clinic for Refugees in 
Copenhagen completed self-ratings of level 
of functioning, quality of life, and symptoms 
of PTSD, depression and anxiety before and 
after treatment. Changes in mental state and 
predictors of change were evaluated in a 
sample that all received well-described and 
comparable treatment.  
Results: 85 patients with PTSD or depres-
sion were included in the analysis. Significant 
improvement and effect size were observed 
on all rating scales (p-value <0.01 and 
Cohen’s d 45-0.68). Correlation analysis 
showed no association between severity of 
symptoms at baseline and the observed 
change. 
Conclusion: Despite methodological 
limitations, the finding of a significant 
improvement on all rating scales is important 
considering that previous follow-up studies 
of comparable patient populations have not 
found significant change in the patients’ 
condition after treatment. 
Keywords: refugee, trauma, CBT, antidepres-
sants, PTSD, treatment outcome
Introduction 
Despite the size of the problem, there is very 
limited knowledge about the efficiency of 
psychiatric treatments for trauma-exposed 
refugees. Typically, the target group suffers 
from post-traumatic stress disorder (PTSD), 
anxiety and depression. According to the 
most recent Cochrane Review, Trauma-
Focused Cognitive Behavioural Therapy 
(TFCBT) is the best documented psycho-
therapeutic treatment for PTSD while 
pharmacological treatment with antidepres-
sants (Selective Serotonergic Reuptake 
Inhibitor (SSRI)) has also proved effective,1,2 
but it has yet to be documented whether a 
combination of the two is more effective than 
using either psychotherapy or pharmacologi-
cal treatment.3 The available results are 
mostly based on studies of other patient 
populations than traumatized refugees, such 
as American war veterans or victims of traffic 
accidents. Whether this knowledge can be 
transferred to severely traumatized refugees 
is unclear. Refugees often have several 
co-morbidities, have suffered many consecu-
tive traumas that often continue after arrival 
in their new country of residence, are subject 
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to numerous psychosocial stressors such as 
insecure legal status and limited income and 
social networks, and their mental health 
problems are often chronic in nature. In 
addition, it is yet to be fully understood how 
the transcultural characteristics of trauma-
tized refugees affect the outcome of treat-
ments. Specific trials on refugees are 
therefore needed. 
A systematic review from 20104 specifi-
cally evaluated trials on refugee populations, 
but only 10 trials had comparable popula-
tions and used an acceptable methodology. 
Even these studies differed with regards to 
ethnic groups, legal status of the patients, 
co-morbidities and outcome measures. 
Several studies of multi-disciplinary treat-
ment for refugee populations in Denmark 
have been published, but they were based on 
small samples receiving ill-defined treatment 
and detected no significant change in the 
condition of the patients.5-9 Thus, knowledge 
of how to address the psychosocial problems 
of traumatized refugees is limited albeit of 
most importance.10  The aim of the present 
study is to evaluate the change in the 
condition of the patients after a combination 
treatment with flexible Cognitive Behavioral 
Therapy (CBT) and antidepressants at a 
trauma clinic for refugees in Copenhagen. 
Participants and Design
The study is a follow-up study with patients 
answering self-ratings before, during and 
after treatment.  All participants were 
screened at the Psychiatric Trauma Clinic for 
Refugees in Copenhagen during the period 
April 2008 to June 2009. The included 
patients were 18 years or older. They had 
experienced trauma related to war or 
persecution, including torture, and suffered 
from disorders such as depression and 
PTSD, which are known to occur after 
traumas. The patients had received a 
minimum treatment of four months’ 
duration including treatment with an 
antidepressant, had received at least four 
consultations with a therapist, and had at 
least two outcome ratings (out of four 
possible) from baseline assessment and 
follow-up. Diagnoses were made according 
to ICD-10 research criteria and all individual 
symptoms were recorded. Patients were 
excluded if diagnosed with a psychosis, 
bipolar disorder (F22-29 of F31) or any 
substance abuse apart from the regular use 
of benzodiazepines according to ICD-10. 
Patients who were in need of hospitalization 
in the general psychiatric system were not 
enrolled in treatment at the clinic.  The study 
was conducted in accordance with the 
Helsinki Declaration and was approved by 
the Danish National Committee on Biomed-
ical Research Ethics as well as by the Danish 
Data Protection Agency. 
Data collection
Data collected during the initial assessment 
(two hours with a physician and one hour 
with a social worker) included self-ratings, a 
clinical assessment of the current psychiatric 
status and a structured interview collecting 
information on trauma, socioeconomic 
situation, previous mental health problems 
and treatment, current physical health 
problems and diagnosis according to the 
ICD-10 research criteria. At every consulta-
tion, treatment methods were recorded and 
the patient’s current clinical condition was 
rated by the health professional responsible 
for the consultation. In addition to the 
self-ratings completed at baseline assessment, 
the same self-report instruments were 
answered before CBT treatment was 
initiated (usually after six weeks) and by the 
end of the treatment. Physicians with 
transcultural psychiatric experience with 
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the assessment and diagnosis of participants. 
If necessary, translation was provided during 
assessment and treatment consultations. All 
self-report questionnaires were translated 
into the six most common languages at the 
clinic (Arabic, Farsi, Bosnian / Serbo-Croa-
tian, Russian, Danish and English), which 
included the language of 86% of the patients. 
The self-ratings included PTSD symp-
toms (Harvard Trauma Questionnaire), 
depression and anxiety symptoms (Hopkins 
Symptom Checklist-25), quality of life 
(WHO-5) and the level of functioning 
(Sheehan Disability Scale). The Hopkins 
Symptom Check List-25 (HSCL-25) and the 
Harvard Trauma Questionnaire (HTQ) are 
internationally used and validated self-report 
rating scales.11-14 HSCL-25 is a shorter 
version of the Symptom Checklist-90 with a 
focus on anxiety and depression symptoms. 
HTQ is used to evaluate PTSD. We used the 
first 16 questions of the symptom part (Part 
IV) of HTQ, which are used to evaluate the 
PTSD-diagnosis according to ICD-10 and 
DSM-IV. Both HSCL-25 and HTQ have 
mainly been used on refugees and torture 
victims. For both scales, individual questions 
have a 1-4 Likert format with 4 the highest 
symptom level. The cut-off value for case 
status of HTQ is 2.5 and of HSCL-25 1.75. 
To assess quality of life we used the WHO-5 
scale, which is a widely used self-adminis-
tered questionnaire with 5 questions (0-5 
point Likert scale with 0 being the lowest 
score and 5 the highest). The theoretical raw 
score ranges from 0 to 25 and is transformed 
into a scale from 0 (worst thinkable well-
being) to 100 (best thinkable well-being) by 
multiplying the score by 4. Thus, higher 
scores mean better well-being.15  The 
Sheehan Disability Scale (SDS) is a self-
report rating scale which assesses the level of 
functioning in terms of family, work and 
social network by using 3 visual analogue 
scales from 0-10 with 10 being the lowest 
possible level of functioning. The score is 
usually reported as the total score of the 
three scales ranging from 0-30. Cut-off is 
considered to be 15 if the total score is 
reported. The scale has been used in a variety 
of psychiatric patient groups.16-17 
Statistical analysis 
The change in self-rating scores between the 
beginning and the end of the treatment was 
evaluated with a paired t-test. An improve-
ment on the HSCL-25, HTQ and SDS 
scales means a decline in the value while an 
improvement on the WHO-5 represents an 
increase in scores. In addition to this, 
Cohen's d was calculated (mean change 
divided by the standard deviation at base-
line)18 to evaluate the effect size of change on 
each self-rating scale and Pearson correla-
tions were used to calculate the correlation 
between outcome measures and correlation 
between baseline and follow-up. Finally, a 
measure of reliable change was calculated19 
for each outcome rating scale. The Reliable 
Change Index (RCI) is a measure of the 
minimum individual change in pre–to 
post-treatment ratings, which is statistically 
significant.20 In addition to descriptive 
statistics, linear univariate and multivariate 
regression models were used to investigate 
possible associations between change in the 
patient’s state and potential predictors of 
change. Change was measured as the 
difference between ratings at baseline and at 
follow-up, and all regression models were 
adjusted for baseline scores. The predictors 
included in the univariate analyses of each 
outcome variable were those mentioned in 
Table 1 and 2 in addition to the following 
predictors related to their trauma and mental 
health history: Being an ex-combatant, 
having been persecuted, having lived in a 
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active in country of origin, lived in asylum 
camp in Denmark, number of different types 
of pre-migratory traumas and not having 
mental health problems. 
Background % N
Health at baseline   
PTSD 87 74
Depression (moderate or severe) 98 83
Reports pain 99 83
Assessed psychotic during treatment 15 13
Treated physical symptoms at assessment 49 41
Untreated physical symptoms at assessment 
(excluding pain and headache)
94 78
Previous psychopharmacological treatment 80 68
Previous treatment including psychotherapy 88 75
Any education 76 58
Working at the time of assessment 10 8
Permanent Resident status 90 65
Trauma   
Experienced war 86 72
Been subjected to torture 54 46
Sex   
Female 53 45
Male 47 40
Main Ethnic Groups   
Iraqi 36 31
Iranian 11 9
Lebanese /Palestinian 15 13
Others 38 32
Translator needed 49 42
Table 1: Overview of the mental health at baseline, socioeconomic vulnerabilities and the components 
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 Mean (min-max) Standard 
deviation
Mean number of years in Denmark 14.5 (2-30) 6.4
Age 43.4 (21-57) 8.0
Mean number of years since first trauma 22.6 (4-46) 8.9
   
Treatment   
Medicines   
Sertraline 24 20
Mianserin 4 3
Sertraline & Mianserin 73 62
Antipsychotics 9 8
Benzodiazepines 9 8
>1 type of psychopharmacological medicines 
during treatment
13 11
Received psychoeducation as part of treat-
ment
99 84
 Mean (min-max) s
Psychoeducation topics covered 5.7 (0-10) 2.3
Session with physician 8.7 (4-14) 1.7
Total duration of treatment (months) 8.2 (5.4-13.1) 1.5
Total number of sessions 22.3 (11-38) 4.2
Sessions with psychologist 13.5 (4-24) 3.4
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In addition to this, the following predic-
tors related to current health and socioeco-
nomic condition were included: social 
isolation, income, number of locations with 
pain, pain in arms, pain in legs, pain in back 
and headache. Variables, which in univariate 
regression models were found to be signifi-
cantly associated with change in the patient’s 
state (p ≤ 0.05), were all included in 
multivariate regression models. HTQ and 
HSCL-25 multivariate models included the 
following predictors: employment, pain in 
the arms, use of a translator, patient suitabil-
ity score, use of case formulation, use of 
thought records, use of values mean number 
of therapy methods used, homework 
compliance and the total number of sessions 
with a psychologist. The psychotherapy-relat-
ed variables are described in detail in a 
separate article.20 All statistical analyses were 
made in STATA 11 (StataCorp LP, College 
Station, TX, USA). 
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Table 2: Change in outcome measured by Hopkin’s Symptom Checklist-25 (depression & anxiety), 
Harvard Trauma Questionnaire (PTSD), Sheehan Disability Scale (level of functioning) and 
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The treatment at the clinic was standardized 
and described in manuals which all physi-
cians and clinical psychologists followed to 
the extent possible (see Figure 1). 
A standard period of six months included 
10 consultations with a doctor experienced 
in transcultural psychiatry who is responsible 
for the medical treatment of the patient. The 
doses of Sertraline and Mianserin and 
change in medication followed the recom-
mendations of The Danish Medicines 
Agency and the Maudsley Prescription 
Guidelines.  The first choice medication was 
Sertraline. It was increased by 25 mg per 
week to a maximum dose of 200 mgs. 
Sertraline could be supplemented with 10-30 
mgs of Mianserin if the patients had trouble 
sleeping. Whenever possible, any other 
psychopharmacological treatment was 
reduced or stopped. In addition, the consul-
tations included psychoeducation about the 
illness, the treatment, life in exile, the role of 
religion, sleep, life-style including relaxation-
exercises, physical and social activities, pain, 
cognitive functions, and the influence of the 
illness on the family. Parallel to the psychop-
harmacological treatment and psychoeduca-
tion, the patients received CBT during 16 
consultations with a clinical psychologist. All 
psychologists had received training in CBT 
and treatment of trauma survivors and were 
regularly supervised by CBT experts. The 
psychotherapy and medical sessions were 
planned to be weekly, but patients from the 
study population did not regularly show up 
for appointments, which tended to increase 
the interval between consultations and the 
overall treatment period as well as to reduce 
the average number of consultations during a 
treatment course (See Figure 1). 
The fidelity with the treatment manual 
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depended on the patient’s ability to cooperate 
in therapy. Therefore, the inclusion criteria 
for this study were slightly more flexible than 
the standardized treatment requirements. 
The patients saw a social worker at least once 
during the treatment period.  
Results
During the study period, 166 patients were 
screened at the clinic. Of these, 21 were 
excluded because of psychosis or drug abuse 
while 17 were not included because they did 
not have a trauma-related diagnosis such as 
PTSD or depression according to ICD-10.  
We excluded 29 patients from analysis 
because they had not received a full treat-
ment course. Finally, 14 patients were 
excluded due to incomplete data (did not 
have 1st and 3rd rating). Thus, the presented 
analyses are based on a study sample 
consisting of 85 patients, which means that 
43 (34%) patients were excluded from the 
final sample because of drop-out of treat-
ment or incomplete data.  The non-com-
pleters did not differ markedly from the 
completers at baseline. Of all ratings, only 
HSCL-25 differed significantly, with a mean 
score for completers of 3.2 and of non-com-
pleters of 3.0 (p=0.05), suggesting margin-
ally less depression and anxiety symptom 
intensity in non-completers compared with 
completers. 
Patients’ background
The majority (77%) of patients came from 
the Middle East. Iraqi patients alone 
comprised 36% of the study population. 
Men and women were almost equally 
represented and the average age was 43 years 
at baseline assessment. The majority of 
patients (86%) had experienced war in their 
country of origin and 54% had been 
subjected to torture. Table 1 shows that 
patients overall had very limited psychosocial 
resources and suffered from several health 
problems. Most of the patients were married 
and had children, but 34% of patients had 
no contact with friends or family in Den-
mark. Among the patients, 90% had perma-
nent resident status in Denmark, but only 
eight patients were employed at baseline 
assessment and half of the patients needed 
translation during treatment despite a mean 
of 14 years spent in Denmark.  The average 
time since first trauma was 23 years indicat-
ing chronic late effects. Of the study sample, 
99% of patients complained of pain, 49% of 
patients had medically treated physical 
symptoms, 94% had unexplained physical 
symptoms and 15% described current or 
previous psychotic symptoms at baseline 
assessment. Patients had either depression or 
PTSD and 85% of patients had both during 
assessment (see Table 1). 
Treatment received
The average treatment-time was eight 
months including on average nine sessions 
with a doctor and 14 psychotherapy 
sessions. All but one patient received 
psychoeducation and an average of 6 out of 
10 possible topics were covered. All the 
patients received manualized CBT including 
exposure, mindfulness and acceptance and 
commitment therapy methods and an 
average of 12 of the 21 CBT methods 
included in the manual were used with each 
patient. The majority of patients (72%) were 
treated with a combination of Mianserin 
(average dose 15 mg) and the SSRI Sertra-
line (average dose 125 mg). The rest of the 
patients received treatment with only one of 
the antidepressants. Of the patients, 11 were 
also treated with antipsychotics and/or 
benzodiazepines after the largest possible 
reduction in psychopharmacological 
treatment at baseline. At baseline 28 patients 
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psychopharmacological drug and 22 patients 
stopped taking benzodiazepines during 
treatment (see Table 1). 
Change in condition
Ratings
At baseline assessment most patients had 
high scores on the self-report rating scales: 
On HTQ the patients had a mean score of 
3.25. On HSCL-25 the mean score was 
3.21. On SDS the baseline mean score was 
8 (10 being the lowest possible level of 
functioning) and the mean WHO-5 score 
was 15 (with 100 being the best possible 
quality of life). Positive changes were seen 
on all rating scales (see Table 2), and they 
were unlikely to be due to chance (p-values 
< 0.0004). The individual items on the 
rating scales which showed the largest 
statistical change during treatment were 
sleep (on WHO-5, HTQ and HSCL-25), 
irritation (HTQ), hopelessness (HTQ and 
HSCL-25), feeling blue, low in energy, 
restlessness and nervousness (HSCL-25). 
There was some improvement in level of 
functioning with regard to work and social 
life. The symptoms that changed the least 
were physical symptoms associated with 
anxiety and depression (like poor appetite, 
trembling and heart pounding), shame and 
feeling of worthlessness and fear (avoid-
ance, fearfulness and being on guard). The 
overall changes on the scales had a mean 
Cohen’s d at about 0.6 (ranging from 0.44 
on the HSCL-25 anxiety scale to 0.67 on 
HTQ), and thus moderate effects of the 
treatment were observed by Cohen’s 
standards at the group level (19). On HTQ 
30% of patients showed reliable change 
from baseline to follow-up, whereas the 
proportion of patients with a statistically 
significant individual change for the other 
rating scales was 35% for HSCL-25 28% 
for WHO-5 and 16% for SDS (see Table 2 
& Figures 2 to 4 for change in condition).
 
Predictors of change
Few parameters seemed to predict change in 
the patient’s condition during treatment. In 
multivariate regression models improvement 
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Figure 3: Change in symptoms
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in HTQ score was negatively associated with 
being on public financial support (ß = 0.42, 
p = 0.01, CI = 0.11-0.74). In addition to 
this, improvement in HSCL-25 scores was 
negatively associated with pain in the arms 
(ß= 0.37, p = 0.03, CI= 0.05-0.68)) in 
multivariate regression. Improvement in SDS 
and WHO-5 scores was not significantly 
associated with any of the potential predic-
tors in multivariate regression analysis. We 
have examined a possible correlation 
between the baseline values and the changes 
in the mental condition by calculating the 
correlation coefficients. They were very close 
to zero for all 4 scales ranging from 0.1 on 
SDS to 0.2 on HSCL-25 and WHO-5.
Discussion
We found significant improvement in the 
patients' symptoms of PTSD (HTQ), 
depression and anxiety (HSCL-25), quality 
of life (WHO-5) and level of functioning 
(SDS), but this study obviously cannot rule 
out the possibility that the observed changes 
over the six-month treatment period 
primarily reflect spontaneous recovery and 
not effects of the administered treatment. 
This must be further investigated in studies 
with control groups and optimally rand-
omized trials. However, the patients reported 
the original trauma to date back more than 
20 years (95% of patients reported trauma to 
be more than 10 years old), and this suggests 
that the observed changes in rating scale 
scores are unlikely to reflect spontaneous 
changes in the condition of the patients. A 
previous study of a similar patient population 
in Denmark found no significant change in 
clinical condition of patients5 and this 
finding corroborates the assumption that our 
findings reflect regression towards the mean. 
However, it is possible that patients seek 
treatment when their condition is at its worst 
and that the improvement observed is 
therefore due to a natural fluctuation in their 
condition.  The observed changes did not 
move the majority of patients beyond the 
cut-off scores on the rating scales, suggesting 
that the majority had clinically significant 
symptoms of depression and PTSD after the 
treatment. However, it would require a 
treatment with a very large effect to move the 
majority of patients below cut-off given the 
very high baseline scores observed on all 
rating scales. 
It has been suggested that standard rating 
scales for symptoms (HTQ and HSCL-25) 
in this patient group are less well-suited to 
measure treatment outcomes.21 For instance, 
a Danish study on a comparable group of 
patients found no changes in symptoms, but 
only changes in level of functioning and 
quality of life at an initial follow-up while 
only changes in symptoms were identified at 
a long-term follow-up.5-7 The present study 
cannot confirm these findings as we see 
similar changes on all rating scales. In 
addition to this, a recent study of the validity 
of HTQ and HSCL-25 in different cultural 
groups has questioned the use of standard 
cut-off values of 2.5 for HTQ and 1.75 for 
HSCL-25, which will influence estimates of 
the number of patients below cut-off.22 
Finally, traumatized refugees suffer from 
many different mental and physical prob-
lems, not only PTSD and depression,23 and 
their trauma-related symptoms have often 
been present for very long periods of time. 
This was not measured with the rating scales 
used in the study. 
The strength of the study is the detailed 
description of the patients at baseline, and of 
the treatment they received.20,23 This study is 
one of the first to evaluate a standardized 
treatment described in detail in manuals and 
documented thoroughly during treatment. 
This has enabled us to ensure that the group 
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which has been one of the many methodo-
logical problems of other studies on refugee 
populations using multi-disciplinary treat-
ment.5,6,8 The lack of well-described treat-
ments may reflect variability in the adminis-
tered treatments or reflect a situation where 
an otherwise standardized treatment has not 
been described in sufficient detail to be 
replicated. This is an important problem 
when comparing treatment outcomes. The 
statistically significant change observed in 
this study may be the result of an efficient 
and standardized intervention that was 
administered to patients in the study sample. 
A correlation has been found in many 
studies between the scores at the beginning 
of the treatment and the changes seen in the 
course of the treatment. This was not the 
case in the present study. The symptoms 
which improved most during treatment were 
sleep, general symptoms of depression and 
general feelings of anxiety. Overall changes in 
rating scores were largest on HTQ. The CBT 
had been designed to address PTSD 
specifically and this might be a reason for the 
significant improvements in PTSD. The 
effects of Sertraline are not only to decrease 
symptoms of depression, but also to decrease 
generalized anxiety24 which might explain 
the changes on these parameters. Finally, the 
overall biggest change in symptoms was with 
regard to sleep (improvement with a large 
statistical effect on all scales measuring 
sleep). This could reflect the use of Mian-
serin, which is known for its positive effect 
on sleep disturbances,25 although we did not 
find a correlation between change in sleep 
items on HSCL-25 and HTQ and Mian-
serin. However, to confirm this a study 
where the individual treatment components 
were evaluated separately would be neces-
sary. For the benefit of future treatment 
development, it would be very important to 
evaluate the effect of the different treatment 
components separately and compare them to 
combination treatment to rule out the 
possibility that each of the components alone 
would have the same effect as the more 
costly combination. This is in accordance 
with the conclusions of a recently published 
Cochrane Review of combination treatment.3 
We found few predictors of treatment 
outcome, but several factors can explain 
these results. The sample size was small and 
we would only be able to detect substantial 
effects of predictors, which may be unlikely. 
The sample was very homogeneous with 
respect to some of the predictors of treat-
ment outcome whereas the distribution of 
others was more heterogeneous. Study 
sample selection means that the treatment 
was similar with regard to duration, number 
of consultations, psychopharmacological 
treatment, psychoeducation and psychother-
apy. Almost all patients suffered from the 
same problems at baseline including pain, 
somatic complaints and several trauma-relat-
ed diseases, and all patients with psychosis, 
bipolar disorder or substance abuse were 
excluded. Furthermore, the patients were 
also homogeneous with respect to socioeco-
nomic factors such as income, legal status, 
and employment (see Table 1). It has been 
suggested that current psychosocial stressors 
may substantially influence treatment 
outcomes in studies of traumatized refu-
gees10 but the literature on the association 
between psychosocial factors and treatment 
outcome is inconclusive.23,26,27 There is some 
evidence that income and economic strain 
influence the condition of traumatized 
refugees.26,28-31 One other Danish study has 
found an association between pain in the 
arms and patient condition in a similar 
sample of refugees.32 There is also evidence 
that post-migratory stressors play an 
increasingly important role in relation to 
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in the receiving country.6,33,34 This could 
explain why we did not find any clear 
association between pre-migratory predictors 
such as type of trauma and change in the 
patients’ condition. 
We found that improvement in depres-
sion and anxiety on HSCL-25 was associated 
with pain in the arms and that being on 
public financial support was negatively 
associated with PTSD improvement. 
Although other pain variables were included 
in the regression analysis only pain in the 
arms was significantly associated with 
treatment outcome in multivariate analysis. 
This could be due to larger variation in pain 
in the arms than the other pain variables. 
However, another study has also found pain 
in the arms to predict patient condition in a 
similar patient sample.32 We found that more 
torture survivors had pain (66%) than those 
who had not endured torture (33%), which 
might partially explain the finding. Chronic 
pain, PTSD and depression has also been 
shown to be related in other studies although 
it remains unclear whether depression is the 
main factor associated with chronic pain or if 
PTSD and anxiety disorders are indepen-
dently related to chronic pain.35-37 
It is not surprising that improvement in 
PTSD is associated with socioeconomic 
conditions. Families living on social welfare 
are living in relative poverty in Denmark and 
have to participate in job training and 
language classes, which is a stressor for many 
patients. The finding that reports of previous 
psychotic symptoms or treatment for 
psychotic symptoms were positively associ-
ated with an improvement in level of 
functioning is interesting. It is possible that 
these patients in previous treatments only 
had received treatment for psychotic disorder 
and not their trauma-related disease.38 If the 
psychotic symptoms are an integral part of 
the trauma-related mental distress they could 
be expected to improve together with other 
trauma-related symptoms. This finding must 
be investigated further in future studies. 
So far, the best results of treatments 
evaluated with randomized trials4 were found 
in populations displaced within their original 
region who received Narrative Exposure 
Therapy39-41 and in a highly selected 
Southeast Asian patient population treated in 
Boston.42-44 It is therefore an important 
finding that our CBT and psychopharmaco-
logical treatment seems to be associated with 
a positive change in the patient condition 
from baseline to follow-up. However, the 
association between treatment and improve-
ment needs to be confirmed in studies 
including a control group and blinded 
ratings including observer-ratings to comple-
ment the subjective evaluations made by 
patients. 
Conclusion
The study showed statistically significant 
changes in the condition of the patients from 
assessment before treatment to follow-up. 
Few other studies have found similar results 
and the observed changes may depend on 
the target patient population. Our population 
is similar to those described in other 
Scandinavian studies5,6,8,45 which found little 
or no change in patient condition after 
treatment. More studies with improved 
methodology using well-described treatment 
on well-characterized patients are necessary, 
and we have now demonstrated that it is 
possible to conduct such studies. Presum-
ably, a more effective treatment of trauma-
tized refugees requires a better classification 
of patient diagnoses reflecting not only 
PTSD, but also co-morbid symptom 
complexes, as well as psychotherapeutic and 
pharmacological treatment directed at all the 
problems of the patient, including somatic 
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our results can be confirmed in future 
studies with better methodology, they might 
indicate that evidence from research in other 
patient populations may be transferable to 
the refugee context. On the other hand, the 
patient population suffers from many other 
problems than PTSD, and consequently 
there are reasons to include other elements 
in the treatment to further improve the 
outcome. 
Acknowledgements
We would like to thank all the employees at 
the Psychiatric Trauma Clinic for Refugees 
who have contributed to collection and 
management of data in the study.  
The article and research project is part of the 
work for a PhD thesis. The project is funded 
by the Capital Region Psychiatry, Denmark, 


























S C I E N T I F I C  A R T I C L E  
References
1.  Bisson J, Andrew M. Psychological treatment of 
post-traumatic stress disorder (PTSD). Cochrane 
Database Syst Rev. 2007 Jul 18;(3).
2.  Stein DJ, Ipser JC, Seedat S. Pharmacotherapy 
for post traumatic stress disorder (PTSD). 
Cochrane Database Syst Rev. 2006 Jan 25;(1).
3.  Hetrick SE, Purcell R, Garner B, Parslow R. 
Combined pharmacotherapy and psychologi-
cal therapies for post traumatic stress disorder 
(PTSD). Cochrane Database Syst Rev. 2010 Jul 
7;(7).
4.  Crumlish N, O'Rourke K. A systematic review 
of treatments for post-traumatic stress disorder 
among refugees and asylum-seekers. J Nerv Ment 
Dis. 2010 Apr;198(4):237-51.
5.  Carlsson JM, Mortensen EL, Kastrup M. A 
follow-up study of mental health and health-
related quality of life in tortured refugees in mul-
tidisciplinary treatment. J Nerv Ment Dis. 2005 
Oct;193(10):651-7.
6.  Carlsson JM, Olsen DR, Mortensen EL, Kastrup 
M. Mental health and health-related quality of 
life: a 10-year follow-up of tortured refugees. J 
Nerv Ment Dis. 2006 Oct;194(10):725-31.
7.  Carlsson JM, Olsen DR, Kastrup M, Mortensen 
EL. Late mental health changes in tortured refu-
gees in multidisciplinary treatment. J Nerv Ment 
Dis. 2010 Nov;198(11):824-8.
8.  Palic S, Elklit A. An explorative outcome study of 
CBT-based multidisciplinary treatment in a di-
verse group of refugees from a Danish treatment 
centre for rehabilitation of traumatized refugees. 
Torture. 2009;19(3):248-70.
9.  Palic S, Elklit A. Psychosocial treatment of post-
traumatic stress disorder in adult refugees: a sys-
tematic review of prospective treatment outcome 
studies and a critique. J Affect Disord. 2011 
Jun;131(1-3):8-23. 10. Nickerson A, Bryant RA, 
Silove D, Steel Z. A critical review of psychologi-
cal treatments of posttraumatic stress disorder in 
refugees. Clin Psychol Rev. 2011 Apr;31(3):399-
417. 
11.  Mollica RF, Caspi-Yavin Y, Bollini P, Truong T, 
Tor S, Lavelle J. The Harvard Trauma Question-
naire. Validating a cross-cultural instrument for 
measuring torture, trauma, and posttraumatic 
stress disorder in Indochinese refugees. J Nerv 
Ment Dis. 1992 Feb;180(2):111-6.
12.  Mollica RF, Wyshak G, de Marneffe D, Khuon 
F, Lavelle J. Indochinese versions of the Hopkins 
Symptom Checklist-25: a screening instrument 
for the psychiatric care of refugees. Am J Psychia-
try. 1987 Apr;144(4):497-500.
13.  Oruc L, Kapetanovic A, Culhane M, Lavelle J, 
Miley K, Forstbauer S, et al. Screening for PTSD 
and depression in Bosnia and Herzegovina: vali-
dating the Harvard Trauma Questionnaire and 
the Hopkins Symptom Cheklist. Int J Culture 
Ment Health. 2008 Dec;1(2):105-116.
14.  Kleijn WC, Hovens JE, Rodenburg JJ. Posttrau-
matic stress symptoms in refugees: assessments 
with the Harvard Trauma Questionnaire and the 
Hopkins symptom Checklist-25 in different lan-
guages. Psychol Rep. 2001 Apr;88(2):527-32.
15.  WHO. Info package; mastering depression in 
primary care Frederiksborg, Denmark: World 
Health Organisation, Regional Office for Europe, 
Psychiatric Research Unit; 1998 [updated 1998]. 
Available from: http://www.who-5.org.
16.  Sheehan KH, Sheehan DV. Assessing treatment 
effects in clinical trials with the discan metric of 
the Sheehan Disability Scale. IntClinPsychophar-
macol. 2008 Mar;23(2):70-83.
17.  Lam RW, Michalak EE, Swinson RP. Assessment 
scales in depression, mania and anxiety. London: 
Taylor & Francis; 2005. p. 152-3.
18.  Cohen J. Statistical power analysis for the behav-
ioural sciences. 2nd ed: Lawrence Erlbaum As-
sociates; 1988.
19.  Jacobson NS, Truax P. Clinical significance: a sta-
tistical approach to defining meaningful change 
in psychotherapy research. J Consult Clin Psy-
chol. 1991 Feb;59(1):12-9.
20.  Buhmann CB, Mortensen EL, Andersen I, Ry-
berg J, Nordentoft M, Ekstroem M. Cognitive 
Behavioral Psychotherapeutic treatment at a psy-
chiatric trauma clinic for Refugees: description 
and evaluation. Torture. 2015;25(1):pp.
21.  Basoglu M. Rehabilitation of traumatised refu-
gees and survivors of torture. BMJ. 2006 Dec 
16;333(7581):1230-1.
22.  Jakobsen M, Thoresen S, Johansen,L.E.E. The 
validity of screening for post-traumatic stress dis-
order and other mental health problems among 
asylum seekers from different countries. Journal 
of Refugee Studies. 2011;24(1):171-86.
23.  Buhmann C, Mortensen EL, Lundstroem S, Ry-
berg J, Nordentoft M, Ekstroem M. Symptoms, 
Quality of Life and level of functioning of trau-
matized refugees at Psychiatric Trauma Clinic in 
Copenhagen. Torture. 2014;24 (1): 25-39.
24.  Sheehan DV, Kamijima K. An evidence-based 
review of the clinical use of sertraline in mood 
and anxiety disorders. Int Clin Psychopharmacol. 
2009 Mar;24(2):43-60.
25.  Mayers AG, Baldwin DS. Antidepressants and 
their effect on sleep. Hum Psychopharmacol. 
2005 Dec;20(8):533-59.





























 S C I E N T I F I C  A R T I C L E
SM, Chun CA. Mental health of Cambodian ref-
ugees 2 decades after resettlement in the United 
States. JAMA. 2005 Aug;294(5):571-9.
27.  Lie B. A 3-year follow-up study of psycho-
social functioning and general symptoms in 
settled refugees. Acta Psychiatr Scand. 2002 
Dec;106(6):415-25.
28.  Blair RG. Risk factors associated with PTSD and 
major depression among Cambodian refugees in 
Utah. Health Soc Work. 2000 Feb;25(1):23-30.
29.  Beiser M, Hou F. Language acquisition, unem-
ployment and depressive disorder among South-
east Asian refugees: a 10-year study. Soc Sci 
Med. 2001 Nov;53(10):1321-34.
30.  Bhui K, Craig T, Mohamud S, Warfa N, Stans-
feld SA, Thornicroft G, et al. Mental disorders 
among Somali refugees: developing culturally 
appropriate measures and assessing socio-cultural 
risk factors. Soc Psychiatry Psychiatr Epidemiol. 
2006 May;41(5):400-8.
31.  Lindencrona F, Ekblad S, Hauff E. Mental health 
of recently resettled refugees from the Middle 
East in Sweden: the impact of pre-resettlement 
trauma, resettlement stress and capacity to han-
dle stress. Soc Psychiatry Psychiatr Epidemiol. 
2008 Feb;43(2):121-31.
32.  Carlsson JM, Mortensen EL, Kastrup M. 
Predictors of mental health and quality of life 
in male tortured refugees. Nord J Psychiatry. 
2006;60(1):51-7.
33.  Gorst-Unsworth C, Goldenberg E. Psychologi-
cal sequelae of torture and organised violence 
suffered by refugees from Iraq. Trauma-related 
factors compared with social factors in exile. Br J 
Psychiatry.  1998 Jan;172:90-4.
34.  Hermansson AC, Timpka T, Thyberg M. 
The mental health of war-wounded refugees: 
an 8-year follow-up. J Nerv MentDis. 2002 
Jun;190(6):374-80.
35.  Asmundson GJ, Coons MJ, Taylor S, Katz J. 
PTSD and the experience of pain: research and 
clinical implications of shared vulnerability and 
mutual maintenance models. Can J Psychiatry. 
2002 Dec;47(10):930-7.
36.  Asmundson GJ, Katz J. Understanding 
the co-occurrence of anxiety disorders and 
chronic pain: state-of-the-art. Depress Anxiety. 
2009;26(10):888-901.
37.  Poundja J, Fikretoglu D, Brunet A. The co-occur-
rence of posttraumatic stress disorder symptoms 
and pain: is depression a mediator? J Trauma 
Stress. 2006 Oct;19(5):747-51.
38.  Moskowitz A. Schizophrenia, trauma, dissocia-
tion, and scientific revolutions. J Trauma Disso-
ciation. 2011;12(4):347-57.
39.  Neuner F, Kurreck S, Ruf M, Odenwald M, 
Elbert T, Schauer M. Can asylum-seekers with 
posttraumatic stress disorder be successfully 
treated? A randomized controlled pilot study. 
Cogn Behav Ther. 2010;39(2):81-91.
40.  Neuner F, Onyut PL, Ertl V, Odenwald M, 
Schauer E, Elbert T. Treatment of posttrau-
matic stress disorder by trained lay counselors 
in an African refugee settlement: a randomized 
controlled trial. J Consult Clin Psychol. 2008 
Aug;76(4):686-94.
41.  Neuner F, Schauer M, Klaschik C, Karunakara 
U, Elbert T. A comparison of narrative exposure 
therapy, supportive counseling, and psychoeduca-
tion for treating posttraumatic stress disorder in 
an african refugee settlement. JConsult ClinPsy-
chol. 2004;72(4):579-87.
42.  Hinton DE, Chhean D, Pich V, Safren SA, Hof-
mann SG, Pollack MH. A randomized controlled 
trial of cognitive-behavior therapy for Cambo-
dian refugees with treatment-resistant PTSD 
and panic attacks: a cross-over design. J Trauma 
Stress. 2005 Dec;18(6):617-29.
43.  Hinton DE, Pham T, Tran M, Safren SA, Otto 
MW, Pollack MH. CBT for Vietnamese refu-
gees with treatment-resistant PTSD and panic 
attacks: a pilot study. J Trauma Stress. 2004 
Oct;17(5):429-33.
44.  Otto MW, Hinton D, Korbly NB, Chea A, Ba 
P, Gershuny BS, et al. Treatment of pharmaco-
therapy-refractory posttraumatic stress disorder 
among Cambodian refugees: a pilot study of 
combination treatment with cognitive-behavior 
therapy vs sertraline alone. Behav Res Ther. 2003 
Nov;41(11):1271-6.
45.  Paunovic N, Ost LG. Cognitive-behavior 
therapy vs exposure therapy in the treatment 
of PTSD in refugees. Behav Res Ther. 2001 
Oct;39(10):1183-97.
